In vitro Propagation of Philodendron spp.: Development and Future Perspectives
International STEM Journal · 30.06.2026 · 7 (1) · 39-47
DOI: 10.22452/stem.vol7no1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift International STEM Journal, online erschienen am 30.06.2026. Verfasst von Arieff Iskandar Heilman Ezmi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
High consumer demand for variegated Philodendron cultivars outpaces the slow multiplication rates of conventional propagation. This review examines recent advances in Philodendron micropropagation as a strategy to overcome this production constraint. Optimized culture protocols incorporating specific cytokinin and auxin combinations have enabled efficient shoot multiplication and vigorous root development. Furthermore, innovations such as the usage of silver nanoparticles (AgNPs) for aseptic establishment and arbuscular mycorrhizal fungi (AMF) for acclimatization significantly improve survival rates of plants. While Temporary Immersion Systems (TIS) offer promising scalability, verifying genetic fidelity remains critical. Collectively, these advanced tissue culture techniques provide a reliable, scalable framework for producing true-to-type, disease-free Philodendron clones for the global ornamental market.
Zitieren
APA
Ezmi, A. I. H., A.Malek, M. T., & Alwakil, N. H. (2026). In vitro Propagation of Philodendron spp.: Development and Future Perspectives. International STEM Journal, 7(1), 39-47. https://doi.org/10.22452/stem.vol7no1.4
Vancouver
Ezmi AIH, A.Malek MT, Alwakil NH. In vitro Propagation of Philodendron spp.: Development and Future Perspectives. International STEM Journal. 2026;7(1):39-47. doi:10.22452/stem.vol7no1.4
BibTeX
@article{Ezmi2026,
author = {Ezmi, Arieff Iskandar Heilman and A.Malek, Mohd Taufik and Alwakil, Nurul Huda},
title = {In vitro Propagation of Philodendron spp.: Development and Future Perspectives},
journal = {International STEM Journal},
year = {2026},
volume = {7},
number = {1},
pages = {39--47},
doi = {10.22452/stem.vol7no1.4}
}
EUVIMED